业界动态国内医卫资讯
FDA要求GLP-1药物标签增加罕见眼部疾病风险
Medscape News · 2026-11-10 03:27
摘要
FDA现在要求GLP-1受体激动剂标签中添加关于非动脉炎性前部缺血性视神经病变潜在风险增加的信息。Medscape Medical News
English
FDA Requires GLP-1 Labels to Add Rare Eye Condition Risk
The FDA now requires information be added to the labels of GLP-1 receptor agonists about the potential increased risk for nonarteritic anterior ischemic optic neuropathy. Medscape Medical News